(Q44618950)

4 December 2017

title

Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins (English)

1 reference

4 December 2017

0 references

1 reference

M Schoenhals

1

1 reference

4 December 2017

C Frecha

2

1 reference

4 December 2017

A Bruyer

3

1 reference

4 December 2017

A Caraux

4

1 reference

4 December 2017

J L Veyrune

5

1 reference

4 December 2017

M Jourdan

6

1 reference

4 December 2017

J Moreaux

7

1 reference

4 December 2017

F-L Cosset

8

1 reference

4 December 2017

E Verhoeyen

9

1 reference

4 December 2017

B Klein

10

1 reference

4 December 2017

publication date

9 February 2012

1 reference

4 December 2017

1 reference

4 December 2017

volume

26

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

1663-1670

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2012.36

4 December 2017

exact match

0 references

cites work

Memory B and memory plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Early genetic events provide the basis for a clinical classification of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Genomics in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

In vivo gene delivery into hCD34+ cells in a humanized mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Mobilization of plasma cells in healthy individuals treated with granulocyte colony-stimulating factor for haematopoietic stem cell collection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Humoral immunotherapy of multiple myeloma: perspectives and perplexities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Competence and competition: the challenge of becoming a long-lived plasma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Lentiviral vectors and transduction of human cancer B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du M

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

7 January 2021

Oncolytic virotherapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

7 January 2021

Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

7 January 2021

Bone marrow mesenchymal stem cells are abnormal in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.36

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.36

1 reference

4 December 2017

1 reference